Gilead Sciences Recommendation
Given the investment horizon of 30 days, and your above average risk tolerance our recommendation regarding Gilead Sciences Inc is 'Hold'
For the selected time horizon Gilead Sciences Inc has a risk adjusted performance of (0.0093)
, jensen alpha of (0.12)
, total risk alpha of (0.53)
, sortino ratio of 0.0 and treynor ratio of (0.70)
Macroaxis provides unbiased buy or sell recommendations on Gilead Sciences that should be used to complement current analysts and expert consensus
on Gilead Sciences. Our buy, hold, or sell suggestion engine determines the entity potential to grow exclusively from the prospective of investors current risk tolerance and investing horizon. To make sure Gilead Sciences Inc is not overpriced, please check out all Gilead Sciences fundamentals including its Gross Profit
, Debt to Equity
and the relationship
between Price to Book
and Cash and Equivalents
. Given that Gilead Sciences
has Number of Shares Shorted
of 15.82 M, we strongly advise you confirm Gilead Sciences market performance and probability of bankruptcy to make sure the company can sustain itself in the current economic cycle given your regular risk tolerance and investing horizon.
Returns Distribution Density
|Mean Return||-0.1||Value At Risk||-1.8555|
|Potential Upside||1.9439||Standard Deviation||2.2014|
Gilead Sciences Greeks
Gilead Sciences Volatility Alert
Gilead Sciences Inc exhibits ver low volatility with skewness of -2.78 and kurtosis of 11.18. However, we advise investors to further study Gilead Sciences Inc technical indicators to make sure all market info is available and is reliable.